Search Results - "Vedin, Inger"
-
1
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers
Published in Journal of Alzheimer's disease (01-01-2013)“…The use of supplements with omega-3 (ω3) fatty acids (FAs) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is widespread due to proposed…”
Get more information
Journal Article -
2
DHA-rich n–3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study
Published in The American journal of clinical nutrition (01-10-2017)“…Abstract Background: Dietary fish oils, rich in long-chain n–3 (ω-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n–3) and eicosapentaenoic acid…”
Get full text
Journal Article -
3
Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study[S]
Published in Journal of lipid research (01-03-2015)“…Specialized proresolving mediators (SPMs) induce resolution of inflammation. SPMs are derivatives of n-3 and n-6 PUFAs and may mediate their beneficial…”
Get full text
Journal Article -
4
Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study
Published in PloS one (24-04-2012)“…Dietary fish oil, rich in n-3 fatty acids (n-3 FAs), e.g. docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), regulate inflammatory reactions by…”
Get full text
Journal Article -
5
Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study
Published in The American journal of clinical nutrition (01-06-2008)“…BACKGROUND:Dietary fish or fish oil rich in n-3 fatty acids (n-3 FAs), eg, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), ameliorate inflammatory…”
Get full text
Journal Article -
6
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms
Published in International journal of geriatric psychiatry (01-02-2008)“…Background Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega‐3 fatty acids (ω3), docosahexaenoic acid (DHA) and…”
Get full text
Journal Article -
7
Reduced prostaglandin F2α release from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study
Published in Journal of lipid research (01-05-2010)“…Omega-3 fatty acids, e.g., dokosahexaenoic acid (DHA) and eikosapentaenoic acid (EPA), ameliorate inflammatory reactions by various mechanisms, but the role of…”
Get full text
Journal Article -
8
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study
Published in Dementia and geriatric cognitive disorders (01-01-2009)“…omega-3 fatty acids (omega-3 FAs) found in dietary fish or fish oils are anti-inflammatory agents that may influence Alzheimer's disease (AD). To study the…”
Get more information
Journal Article -
9
Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study
Published in Journal of Alzheimer's disease (01-01-2015)“…ω3 fatty acids (ω3 FAs) may slow the rate of decline in cognitive performance in mild forms of cognitive impairment and Alzheimer's disease (AD). However, the…”
Get more information
Journal Article -
10
The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
Published in Leukemia (01-04-2013)“…Refractory anemia with ring sideroblasts (RARS) is characterized by mitochondrial ferritin (FTMT) accumulation and markedly suppressed expression of the iron…”
Get full text
Journal Article -
11
DHA-rich n–3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study123
Published in The American journal of clinical nutrition (01-04-2017)“…Dietary fish oils, rich in long-chain n–3 (ω-3) fatty acids (FAs) [e.g., docosahexaenoic acid (DHA, 22:6n–3) and eicosapentaenoic acid (EPA, 20:5n–3)],…”
Get full text
Journal Article -
12
Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study
Published in Journal of Alzheimer's disease (01-01-2014)“…Oxidative stress and inflammation are two key mechanisms suggested to be involved in the pathogenesis of Alzheimer's disease (AD). Omega-3 fatty acids (ω-3…”
Get more information
Journal Article -
13
Effect of FCGR polymorphism on the occurrence of late-onset neutropenia and flare-free survival in rheumatic patients treated with rituximab
Published in Arthritis research & therapy (07-03-2017)“…The causes and mechanisms of late-onset neutropenia (LON) following rituximab treatment in patients with rheumatic diseases are not known. In this study, we…”
Get full text
Journal Article -
14
Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A
Published in International journal of molecular medicine (01-02-2015)“…A prospective clinical study was carried out to investigate whether endometrial microvessels in patients with idiopathic heavy menstrual bleeding (HMB) of…”
Get full text
Journal Article -
15
X‐linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: Comparisons with primary myelofibrosis
Published in American journal of hematology (01-03-2015)“…X‐linked thrombocytopenia with thalassemia (XLTT) is caused by the mutation 216R > Q in exon 4 of the GATA1 gene. Male hemizygous patients display…”
Get full text
Journal Article -
16
Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?
Published in Journal of Alzheimer's disease (01-01-2018)“…Low tissue levels of the major marine ω3 fatty acids (FAs) DHA and EPA are found in Alzheimer's disease (AD). We investigated if healthy proxies to AD patients…”
Get more information
Journal Article -
17
Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study
Published in Journal of Alzheimer's disease (01-01-2013)“…Transthyretin (TTR) binds amyloid-β (Aβ) and may reduce brain Aβ, a pathological feature in Alzheimer's disease (AD). N - 3 fatty acids (FA), docosahexaenoic…”
Get more information
Journal Article -
18
Omega-3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega-3 Alzheimer's Disease Study
Published in Journal of the American Geriatrics Society (JAGS) (01-01-2009)“…OBJECTIVES: To study the effects of omega (Ω)‐3 fatty acid (FA) supplements on weight and appetite in patients with mild to moderate Alzheimer's disease (AD)…”
Get full text
Journal Article -
19
-
20